Showing results (81-90 of 181) with videos related to
Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 1998
Malignant effusions contain lysophosphatidic acid (LPA)-like activityA M Westermann, E Havik, F R Postma, et al.British Journal of Haematology|December 1, 1985
Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?O A van Dobbenburgh, S Rodenhuis, T Ockhuizen, et al.European Journal of Clinical Pharmacology|November 9, 2001
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide and metabolites after a 72-h continuous infusion in patients with soft tissue sarcomaT Kerbusch, R A Mathĵt, H J Keizer, et al.Cancer Chemotherapy and Pharmacology|April 1, 1999
A single 24-hour plasma sample does not predict the carboplatin AUC from carboplatin-paclitaxel combinations or from a high-dose carboplatin-thiotepa-cyclophosphamide regimenV R Panday, L J van Warmerdam, M T Huizing, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II studyG Stoter, S Aamdal, S Rodenhuis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective studyS Rodenhuis, L Boerrigter, B Top, et al.Blood|February 7, 2001
In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantationC Voermans, M L Kooi, S Rodenhuis, et al.International Journal of Cancer|April 21, 1995
Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancerB Top, W J Mooi, S G Klaver, et al.Nederlands Tijdschrift Voor Geneeskunde|January 30, 1993
[Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy]D J Richel, J W Baars, M J Wijngaarden, et al.European Journal of Cancer & Clinical Oncology|April 1, 1984
Patient motivation and informed consent in a phase I study of an anticancer agentS Rodenhuis, W J van den Heuvel, A A Annyas, et al.Pageof 19